Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease

✍ Scribed by Seiji Ueda; Sho-ichi Yamagishi; Yuriko Matsumoto; Kei Fukami; Seiya Okuda

• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 233 KB
• Volume: 11
• Category: Article
• ISSN: 1342-1751
• DOI: 10.1007/s10157-007-0471-x